Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Larimar Therapeutics EPS - Earnings per Share 2012-2024 | LRMR

Larimar Therapeutics eps - earnings per share from 2012 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  
Larimar Therapeutics Annual EPS
2023 $-0.84
2022 $-1.37
2021 $-2.95
2020 $-3.57
2019 $-3.80
2018 $-22.81
2017 $-22.81
2016 $-25.45
2015 $-33.37
2014 $-36.01
2013 $-234.45
2012 $-235.89
2011 $-230.13
Larimar Therapeutics Quarterly EPS
2024-03-31 $-0.27
2023-12-31 $-0.29
2023-09-30 $-0.21
2023-06-30 $-0.19
2023-03-31 $-0.15
2022-12-31 $-0.04
2022-09-30 $-0.37
2022-06-30 $-0.47
2022-03-31 $-0.49
2021-12-31 $-0.48
2021-09-30 $-0.92
2021-06-30 $-0.79
2021-03-31 $-0.76
2020-12-31 $-0.62
2020-09-30 $-0.64
2020-06-30 $-1.21
2020-03-31 $-1.10
2019-12-31 $2.43
2019-09-30 $-1.42
2019-06-30 $-0.61
2019-03-31 $-4.20
2018-12-31 $-4.08
2018-09-30 $-4.92
2018-06-30 $-6.84
2018-03-31 $-6.96
2017-12-31 $-5.64
2017-09-30 $-5.52
2017-06-30 $-5.88
2017-03-31 $-5.76
2016-12-31 $-4.56
2016-09-30 $-6.48
2016-06-30 $-6.60
2016-03-31 $-7.80
2015-12-31 $-10.32
2015-09-30 $-8.76
2015-06-30 $-7.92
2015-03-31 $-6.36
2014-12-31 $81.51
2014-09-30 $-7.80
2014-06-30 $-35.53
2014-03-31 $-74.19
2013-12-31 $-64.23
2013-09-30 $-58.58
2013-06-30 $-52.46
2013-03-31 $-59.30
2012-12-31 $0.00
2011-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.464B $0.000B
Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.573B 32.35
Chugai Pharmaceutical (CHGCY) Japan $52.837B 23.62
Takeda Pharmaceutical (TAK) Japan $42.029B 8.51
Merck (MKGAF) Germany $23.651B 22.93
Astellas Pharma (ALPMY) Japan $17.445B 27.54
Sandoz Group AG (SDZNY) Switzerland $15.171B 0.00
Neurocrine Biosciences (NBIX) United States $14.255B 39.02
Shionogi (SGIOY) Japan $13.463B 11.70
United Therapeutics (UTHR) United States $12.183B 12.99
Catalent (CTLT) United States $9.954B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.847B 7.53
Revolution Medicines (RVMD) United States $6.604B 0.00
Ionis Pharmaceuticals (IONS) United States $5.652B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.946B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.992B 0.00
Summit Therapeutics (SMMT) United States $3.187B 0.00
Dyne Therapeutics (DYN) United States $3.092B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.083B 0.00
PTC Therapeutics (PTCT) United States $3.077B 0.00
Corcept Therapeutics (CORT) United States $3.007B 27.25
Indivior (INDV) United States $2.356B 11.17
Recursion Pharmaceuticals (RXRX) United States $2.295B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.077B 11.81
Catalyst Pharmaceuticals (CPRX) United States $1.999B 19.45
Evotec AG (EVO) Germany $1.846B 0.00
Ardelyx (ARDX) United States $1.845B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.831B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.785B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 23.97
Soleno Therapeutics (SLNO) United States $1.571B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.509B 0.00
Xencor (XNCR) United States $1.464B 0.00
Pacira BioSciences (PCRX) United States $1.425B 13.54
4D Molecular Therapeutics (FDMT) United States $1.344B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.265B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.117B 6.68
Cronos Group (CRON) Canada $1.062B 0.00
Cassava Sciences (SAVA) United States $1.060B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.005B 15.66
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.927B 15.15
Relay Therapeutics (RLAY) United States $0.900B 0.00
ARS Pharmaceuticals (SPRY) United States $0.890B 0.00
ProKidney (PROK) United States $0.890B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.876B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.825B 0.00
Silence Therapeutics (SLN) United Kingdom $0.699B 0.00
Lyell Immunopharma (LYEL) United States $0.681B 0.00
Sage Therapeutics (SAGE) United States $0.673B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.655B 0.00
Exscientia (EXAI) United Kingdom $0.627B 0.00
Harrow (HROW) United States $0.594B 0.00
Savara (SVRA) United States $0.576B 0.00
Altimmune (ALT) United States $0.570B 0.00
Siga Technologies (SIGA) United States $0.537B 6.86
Corbus Pharmaceuticals Holdings (CRBP) United States $0.519B 0.00
OmniAb (OABI) United States $0.514B 0.00
Heron Therapeutics (HRTX) United States $0.512B 0.00
Korro Bio (KRRO) United States $0.506B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Verve Therapeutics (VERV) United States $0.500B 0.00
Bioventus (BVS) United States $0.493B 18.88
Esperion Therapeutics (ESPR) United States $0.470B 0.00
Lexeo Therapeutics (LXEO) United States $0.454B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Tourmaline Bio (TRML) United States $0.373B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.367B 69.25
Nanobiotix S.A (NBTX) France $0.341B 0.00
Fractyl Health (GUTS) United States $0.334B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Xeris Biopharma Holdings (XERS) United States $0.304B 0.00
Aquestive Therapeutics (AQST) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.95
ESSA Pharma (EPIX) Canada $0.277B 0.00
Black Diamond Therapeutics (BDTX) United States $0.276B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Metagenomi (MGX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Akebia Therapeutics (AKBA) United States $0.241B 0.00
Aldeyra Therapeutics (ALDX) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.239B 0.00
Prelude Therapeutics (PRLD) United States $0.226B 0.00
Conduit Pharmaceuticals (CDT) United States $0.215B 0.00
Avita Medical (RCEL) United States $0.211B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Adherex Technologies (FENC) United States $0.200B 243.67
Galectin Therapeutics (GALT) United States $0.196B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Century Therapeutics (IPSC) United States $0.194B 0.00
CytoDyn (CYDY) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Elite Pharmaceuticals (ELTP) United States $0.158B 14.78
Context Therapeutics (CNTX) United States $0.149B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
OptiNose (OPTN) United States $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.125B 8.36
FibroGen (FGEN) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
PMV Pharmaceuticals (PMVP) United States $0.114B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.100B 0.00
SCYNEXIS (SCYX) United States $0.099B 1.39
Assertio Holdings (ASRT) United States $0.099B 4.52
Relmada Therapeutics (RLMD) United States $0.098B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.064B 0.00
Protara Therapeutics (TARA) United States $0.062B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Nutriband (NTRB) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Lipocine (LPCN) United States $0.034B 0.00
DURECT (DRRX) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.030B 0.00
JanOne (JAN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.15